Un ERC Synergy pour cartographier la représentation du temps par le cerveau
法国原子能与替代能源委员会（CEA）研究员Virginie van Wassenhove等四位科学家联合发起的"Chronology"项目，近日获得欧洲研究理事会（ERC）的"协同资助"。该资助最高可达1000万欧元，为期五年。
项目核心目标是系统解析大脑构建"时间认知地图"的神经机制。研究团队将整合神经科学、心理学与计算建模方法，旨在揭示大脑如何编码、存储和利用时间信息来组织记忆与预测未来。
这一高额资助凸显了时间认知神经机制研究的前沿性与复杂性。研究成果有望为理解记忆障碍、神经系统疾病及开发新型人工智能时间处理模型提供关键理论基础。
Major European Grant Funds Ambitious Study of How the Brain Maps Time
A major neuroscience project, named Chronology, has been awarded a prestigious and highly competitive ERC Synergy grant from the European Research Council. The funding, which can reach up to 10 million euros over five years, will support a team of four researchers, including Virginie van Wassenhove from the French Alternative Energies and Atomic Energy Commission (CEA).
The project's core objective is to fundamentally advance the understanding of how the human brain represents and processes time. Researchers aim to characterize the "cognitive maps of time"—the neural frameworks and mechanisms the brain uses to perceive, remember, and anticipate temporal sequences and durations.
This significant investment will enable the interdisciplinary team to pursue large-scale, cutting-edge experiments to decode the neural signatures of temporal cognition, a complex and still poorly understood area of neuroscience.
Le projet Chronology, associant quatre chercheurs dont Virginie van Wassenhove du CEA, reçoit un ERC Synergy dont le montant peut atteindre 10 millions d'euros pour cinq ans. Objectif : caractériser les cartes cognitives du temps mises en place par le cerveau.
A CEA-linked research team won an ERC Synergy grant of up to €10 million to study how the brain maps and represents time, which could advance neuroscience and cognitive computing.
CEA — French public research organization, based in France.
Virginie van Wassenhove — neuroscientist/researcher at CEA, based in France.
ERC — European Research Council, EU-based research funding body.
Monitor — important research funding news with potential long-term implications for AI and neurotech, but no immediate commercial product.